Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

G. Hudes; M. Carducci; P. Tomczak; J. Dutcher; R. Figlin; A. Kapoor; E. Staroslawska; J. Sosman; D. McDermott; I. Bodrogi; Z. Kovacevic; V. Lesovoy; I. G. Schmidt-Wolf; O. Barbarash; E. Gokmen; T. O'Toole; S. Lustgarten; L. Moore; R. J. Motzer

doi:10.1016/j.juro.2007.10.039

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

G. Hudes, M. Carducci, P. Tomczak, J. Dutcher, R. Figlin, A. Kapoor, E. Staroslawska, J. Sosman, D. McDermott, I. Bodrogi, Z. Kovacevic, V. Lesovoy, I. G. Schmidt-Wolf, O. Barbarash, E. Gokmen, T. O'Toole, S. Lustgarten, L. Moore, R. J. Motzer

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	497-498
Number of pages	2
Journal	Journal of Urology
Volume	179
Issue number	2
DOIs	https://doi.org/10.1016/j.juro.2007.10.039
State	Published - Feb 2008
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2007.10.039

Cite this

Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., Kovacevic, Z., Lesovoy, V., Schmidt-Wolf, I. G., Barbarash, O., Gokmen, E., O'Toole, T., Lustgarten, S., Moore, L., & Motzer, R. J. (2008). Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Journal of Urology, 179(2), 497-498. https://doi.org/10.1016/j.juro.2007.10.039

Hudes, G, Carducci, M, Tomczak, P, Dutcher, J, Figlin, R, Kapoor, A, Staroslawska, E, Sosman, J, McDermott, D, Bodrogi, I, Kovacevic, Z, Lesovoy, V, Schmidt-Wolf, IG, Barbarash, O, Gokmen, E, O'Toole, T, Lustgarten, S, Moore, L & Motzer, RJ 2008, 'Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma', Journal of Urology, vol. 179, no. 2, pp. 497-498. https://doi.org/10.1016/j.juro.2007.10.039

@article{a6aa345bb4be40a4b2661f09e238b58d,

title = "Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma",

author = "G. Hudes and M. Carducci and P. Tomczak and J. Dutcher and R. Figlin and A. Kapoor and E. Staroslawska and J. Sosman and D. McDermott and I. Bodrogi and Z. Kovacevic and V. Lesovoy and Schmidt-Wolf, {I. G.} and O. Barbarash and E. Gokmen and T. O'Toole and S. Lustgarten and L. Moore and Motzer, {R. J.}",

year = "2008",

month = feb,

doi = "10.1016/j.juro.2007.10.039",

language = "English (US)",

volume = "179",

pages = "497--498",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

AU - Hudes, G.

AU - Carducci, M.

AU - Tomczak, P.

AU - Dutcher, J.

AU - Figlin, R.

AU - Kapoor, A.

AU - Staroslawska, E.

AU - Sosman, J.

AU - McDermott, D.

AU - Bodrogi, I.

AU - Kovacevic, Z.

AU - Lesovoy, V.

AU - Schmidt-Wolf, I. G.

AU - Barbarash, O.

AU - Gokmen, E.

AU - O'Toole, T.

AU - Lustgarten, S.

AU - Moore, L.

AU - Motzer, R. J.

PY - 2008/2

Y1 - 2008/2

UR - http://www.scopus.com/inward/record.url?scp=77956492524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956492524&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2007.10.039

DO - 10.1016/j.juro.2007.10.039

M3 - Comment/debate

AN - SCOPUS:77956492524

SN - 0022-5347

VL - 179

SP - 497

EP - 498

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this